Serologic, radiographic, and tissue-based markers associated with major pathologic response after treatment with neoadjuvant immunotherapy in patients with resectable hepatocellular carcinoma.

Autor: LaPelusa, Michael Brian, Chamseddine, Shadi, Xiao, Lianchun, Hasanov, Elshad, Bhosale, Priya, Abugabal, Yehia I., Gok Yavuz, Betul, Yadav, Shalini S., Tran Cao, Hop Sanderson, Xu, Li, Hu, Zishuo Ian, Lee, Sunyoung S., Sakamuri, Divya, Curran, Michael A., Jindal, Sonali, Duda, Gabriel Dan, Sharma, Padmanee, Qayyum, Aliya, Kaseb, Ahmed Omar

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p561-561, 151p

Characterization of outcomes and genomic alterations (GA) in combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA).

Autor: Haro-Silerio, Jaime, Fox, Daniel Aaron, Bhamidipati, Deepak, Hu, Zishuo Ian, Koay, Eugene Jon, Ludmir, Ethan B., Tran Cao, Hop Sanderson, Vauthey, Jean-Nicolas, Newhook, Timothy E., Tzeng, Ching-Wei D., Chun, Yun Shin, Mahvash, Armeen, Metwalli, Zeyad, Habibollahi, Peiman, Cox, Veronica L., Kang, Hyunseon, Chatterjee, Deyali, Kaseb, Ahmed Omar, Javle, Milind M., Lee, Sunyoung S.

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p458-458, 151p

Tissue and Imaging Biomarkers of Response to Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Patients with Resectable Hepatocellular Carcinoma.

Autor: LaPelusa, Michael¹ (AUTHOR) aliya.qayyum@moffitt.org, Chamseddine, Shadi² (AUTHOR), Tran Cao, Hop Sanderson³ (AUTHOR), Xiao, Lianchun⁴ (AUTHOR), Hasanov, Elshad⁵ (AUTHOR), Bhosale, Priya⁶ (AUTHOR), Amin, Hesham M.⁷ (AUTHOR), Mohamed, Yehia I.² (AUTHOR), Gok Yavuz, Betul⁸ (AUTHOR), Sakr, Yara³ (AUTHOR), Xu, Li² (AUTHOR), Hu, Ian² (AUTHOR), Lee, Sunyoung S.² (AUTHOR), Sakamuri, Divya² (AUTHOR), Jindal, Sonali⁹ (AUTHOR), Nguyen, Van¹⁰ (AUTHOR), Curran, Michael A.¹¹ (AUTHOR), Sun, Ryan⁴ (AUTHOR), Rashid, Asif¹² (AUTHOR), Duda, Dan Gabriel¹³ (AUTHOR)

Publikováno v: Oncology. Oct2024, p1-8. 8p. 4 Illustrations, 3 Charts.

Dose-escalated pancreas radiotherapy for unresected pancreatic adenocarcinoma: Patterns of care and survival in the United States.

Autor: Shi, Christopher, De, Brian, Florez, Marcus A., Tran Cao, Hop Sanderson, Lee, Sunyoung S., Willis, Jason, Noticewala, Sonal S, Minsky, Bruce D., Smith, Grace L., Holliday, Emma, Taniguchi, Cullen M., Koong, Albert C., Das, Prajnan, Ludmir, Ethan B., Koay, Eugene Jon

Publikováno v: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p676-676, 1p

Severe febrile neutropenia and pancytopenia in a patient with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: a case report.

Autor: Chamseddine S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LaPelusa M; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carter K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nguyen V; Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sakr Y; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rojas-Hernandez CM; Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hatia RI; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hassan M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Goss JA; Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, USA., Elsayes KM; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rashid A; Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tran Cao HS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: Journal of gastrointestinal oncology [J Gastrointest Oncol] 2024 Jun 30; Vol. 15 (3), pp. 1324-1330. Date of Electronic Publication: 2024 Jun 19.